Cefprozil Monohydrate

头孢丙烯

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCefprozil Monohydrate
Drug Alias Namecefprozilo施复捷cefprozilum头孢普齐头孢罗齐 +[13] 
ClassificationSmall molecules > Heterocyclic drugs > AntibioticsSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsUncomplicated skin and skin structure infectionsLower Respiratory Tract InfectionsOtitis Media +[10] 
Global Approved IndicationsUncomplicated skin and skin structure infectionsLower Respiratory Tract InfectionsOtitis Media +[10] 
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryUnited States
Original Approved Date1991/12/23
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesCorden Pharma
China Registration ClassN/A

Develop Information

Active CompaniesSino--American Shanghai Squibb Pharmaceutical Ltd
Inactive CompaniesSandozCorden Pharma Latina SpaTeva Pharmaceuticals Usa Inc
Active IndicationsBacterial Infections
Inactive IndicationsUncomplicated skin and skin structure infectionsLower Respiratory Tract InfectionsOtitis Media +[9] 

Other Information

ATC CodeJ01DC10
Related LinksWikipediaDrugBankKEGG